Abstract:Background To investigate the association between walking pace and lung cancer risk, and explore whether any association is modified by endurance and power-related genes. Methods We followed up 449,890 UK Biobank participants free of cancer at baseline. Data on self-reported walking pace were collected by touchscreen questionnaire at baseline. Blood samples were obtained for genotyping. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for lung cancer incidence and mortality, with slow walking pace as the reference. Findings 4,087 lung cancer incident cases and 2,245 lung cancer deaths were identified during a median follow-up period of 12.1 and 12.7 years, respectively. For incident lung cancer, HR (95% CI) were 0.71 (0.65- 0.78) and 0.55 (0.49-0.61) among participants with steady and brisk walking pace, respectively. For lung cancer mortality, steady and brisk walking paces were associated with 32% and 48% lower risks, respectively. Associations of walking pace with risks of lung cancer occurrence and mortality were modified by rs1815739 in ACTN3 and rs7191721 in RBFOX1 . The protective effect of faster walking pace was more evident among participants carrying a higher number of T allele for rs1815739 in ACTN3 ( P interaction=0.04 for both lung cancer incidence and mortality) and A allele for rs7191721 in RBFOX1 ( P interaction=0.01 for lung cancer incidence, P interaction=0.004 for lung cancer mortality). Interpretation Faster walking pace is associated with lower risks of both lung cancer occurrence and mortality, and this protective effect is modulated by polymorphisms in endurance gene RBFOX1 and in power gene ( ACTN3 ). Funding This work was supported by grants from the China Postdoctoral Science Foundation (Grant No. BX2021021, 2022M710249), Fujian Provincial Health Technology Project (Grant No. 2020CXB009), and the Natural Science Foundation of Fujian Province, China (Grant No. 2021J01352). ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was funded by grants from the China Postdoctoral Science Foundation (Grant No. BX2021021, 2022M710249), Fujian Provincial Health Technology Project (Grant No. 2020CXB009), and the Natural Science Foundation of Fujian Province, China (Grant No. 2021J01352). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee/IRB of the National Information Governance Board for Health and Social Care and the National Health Service North West Multi-Centre Research Ethics Committee gave ethical approval for this work(Ref 11/NW/0382). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced are available online at UK Biobank (https://www.ukbiobank.ac.uk/).

Walking Pace and Microvascular Complications among Individuals with Type 2 Diabetes: A Cohort Study from the UK Biobank.

Association between walking pace and risks of major chronic diseases in individuals with hypertension based on a prospective study in UK Biobank: Involvement of inflammation

Self-Reported Walking Pace and Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study

Walking pace and the time between the onset of noncommunicable diseases and mortality: a UK Biobank prospective cohort study

Association between grip strength, walking pace and incident peripheral artery disease: A prospective study of 430,886 UK biobank participants

Body Mass Index, Walking Pace, and Risk of Coronary Heart Disease: a Mendelian Randomization and Mediation Analysis

Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population

Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study

Accelerometer-measured physical activity, sedentary behavior, and incidence of macrovascular and microvascular events in individuals with type 2 diabetes mellitus and prediabetes

Mendelian randomisation and mediation analysis of self-reported walking pace and coronary artery disease

Association of a Healthy Lifestyle with All-Cause and Cause-Specific Mortality among Individuals with Type 2 Diabetes: A Prospective Study in UK Biobank

Association between subjective walking speed and metabolic diseases in individuals with obesity: a cross-sectional analysis

Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study

Walking Pace, Sport Genes, and the Lung Cancer

Abstract 13759: Adherence to Healthy Lifestyle is Associated with Lower Total and Cause-Specific Mortality Risk among Patients with Diabetes: the UK Biobank Study

Could poor glycaemic control be a predictor of walking speed decline in older adults? Evidence from the English Longitudinal Study of Ageing

Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations

Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: a Meta-Analysis.

Endurance and power genes modify the protective effect of fast walking pace on lung cancer risk: a UK Biobank prospective cohort study

Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy--results from the Baltimore Longitudinal Study of Aging

Increased walking pace reduces the rate of erectile dysfunction: results from a multivariable Mendelian randomization study